Thursday, March 28, 2024

Tag: Clinical Trial

The Year in Review: SCI Research Breakthroughs in 2015

As we cross the threshold into 2016, we are one step closer to our goal of finding a cure for paralysis. Moving full speed ahead...

Motor Improvement Seen in Patients with Cervical Spinal Cord Injury After Stem Cell Implantation

After six months, the patients in the StemCells, Inc. trial being conducted at University of Miami Hospital are demonstrating improvements in both strength and...

Stem cell research for spinal cord injury

Spinal cord injury (SCI) involves damage to the area that can cause an impairment of loss of muscle control, movement and sensation.  Currently, patients...

A shattering crash, an online chronicle, and an unexpected twist

In the age of social media, patients who test experimental treatments wield surprising clout. The tweets and the selfies, the uploaded video clips, felt like a natural way for Jesi Stracham to record her halting progress as she fought to recover from a motorcycle accident that had left her paralyzed from the chest down. She had no idea, as she tapped away at her iPhone from her hospital bed, what her bubbly posts would unleash.

Regenerating nerve tissue in spinal cord injuries

Rush begins participation in novel study using stem cells to treat spinal cord injuries Researchers at Rush University Medical Center are exploring a new therapy using stem cells to treat spinal cord injuries within the first 14 to 30 days of injury. Rush is only the second center in the country currently studying this new approach.

Olfactory cells transplanted to treat spinal cord injury

Three years after they treated patients with spinal cord injury in a randomized clinical trial with transplanted cells from the patients' olfactory mucosa (nasal...

‘Exciting’ progress for spinal injury drug

Pioneers in the field of neurological therapy want paramedics to be armed with a breakthrough drug to quickly stop the damage spreading. It's the latest...

India to participate in first clinical study trial to treat spinal cord injury using...

By involving 18 patients, India will soon become a part of a first-of-its-kind clinical trial, a collaborative study conducted in China, Norway and America,...

Asterias begins enrollment for AST-OPC1 Phase 1/2a trial to treat complete cervical spinal cord...

Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading biotechnology company in the emerging field of regenerative medicine, announced today that Atlanta-based Shepherd Center, one...

Stem cells from human embryos prove safe, improve vision -study

(Reuters) - The longest-running trial of stem cells derived from a human embryo found that the cells caused patients none of the problems scientists...